People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Model Medicines, Inc. | — | Biotechnology | Series A | $22.5M | $9.0M | 2020 |
| NestGSV, Inc. | — | Other | Series A | $12.5M | $84.2M | 2015 |
| Cardinal Legacy, LLC | — | Other | Pre-Seed | $375K | $858K | 2025 |
Marlon Evans at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marlon Evans on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Moe | 1 | 5 |
| Mark Flynn | 1 | 2 |
| David Pottruck | 1 | 2 |
| DANIEL HADERS | 1 | 2 |
| Kathleen H. Policy | 1 | 1 |
| Vernon H. Stevenson | 1 | 1 |
| David H. Pottruck | 1 | 1 |
| Mark H. Flynn | 1 | 1 |
| Marlon H. Evans | 1 | 1 |
| Kip Quackenbush | 1 | 1 |
| Kit Rodgers | 1 | 1 |
| Alec Wright | 1 | 1 |
| Tim Vago | 1 | 1 |
| Kayvan H. Baroumand | 1 | 1 |
| Sreekanth H. Ravi | 1 | 1 |
| Michael H. Moe | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.